$The Singapore heart failure outcomes and phenotypes (SHOP) study and prospective evaluation of outcome in patients with heart failure with preserved left ventricular ejection fraction (PEOPLE) study: Rationale and design$

The Singapore heart failure outcomes and phenotypes (SHOP) study and prospective evaluation of outcome in patients with heart failure with preserved left ventricular ejection fraction (PEOPLE) study: Rationale and design

10.1016/j.cardfail.2013.01.007

Saved in:

Bibliographic Details
Main Authors:	Santhanakrishnan, Rajalakshmi, Ng, Tze Pin, Cameron, Vicky A., Gamble, Greg D., Ling, Lieng H., Sim, David, Leong, Gerard Kui Toh, Yeo, Poh Shuan Daniel, Ong, Hean Yee, Jaufeerally, Fazlur, Wong, Raymond Ching-Chiew, Chai, Ping, Low, Adrian F., Lund, Mayanna, Devlin, Gerry, Troughton, Richard, Richards, A. Mark, Doughty, Robert N., Lam, Carolyn S. P.
Other Authors:	PSYCHOLOGICAL MEDICINE
Format:	Article
Published:	Elsevier 2013
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/48245
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype
by: Fitzsimons, Sarah, et al.
Published: (2023)

Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand
by: Teng, Tiew-Hwa Katherine, et al.
Published: (2023)

Cornell product is an ECG marker of heart failure with preserved ejection fraction
by: Tan, Eugene SJ, et al.
Published: (2023)

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: The Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial
by: Lam, C.S.P., et al.
Published: (2016)

BIOMECHANICS OF HEART FAILURE WITH PRESERVED EJECTION
by: ZHENG YU
Published: (2023)

Association of Prior Left Ventricular Ejection Fraction with Clinical Outcomes in Patients with Heart Failure with Midrange Ejection Fraction
by: Alison Brann, et al.
Published: (2020)

Obesity and heart failure with preserved ejection fraction
by: Wattana Leowattana
Published: (2020)

Growth differentiation factor 15, ST2, high-sensivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction
by: Santhanakrishnan, Rajalakshmi, et al.
Published: (2013)

Prevalence, clinical correlates, and outcomes of anaemia in multi-ethnic asian patients with heart failure with reduced ejection fraction
by: Vera J. Goh, et al.
Published: (2019)

Patient-reported outcomes in heart failure with preserved vs. reduced ejection fraction: focus on physical independence
by: Huang, W., et al.
Published: (2021)

Heart failure with preserved ejection fraction in women: The dutch queen of hearts program
by: den Ruijter H, et al.
Published: (2016)

Relationship between Serum Dehydroepiandrosterone Levels and Heart Ejection Fraction in Heart Failure Patients
by: Rima Hayyu Chrisnanda, -, et al.

Circulating neuregulin1-? in heart failure with preserved and reduced left ventricular ejection fraction
by: Hage, C., et al.
Published: (2021)

Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry
by: MacDonald, M.R., et al.
Published: (2021)

Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction
by: Yap, J., et al.
Published: (2021)

Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes
by: Wong, Lee Lee, et al.
Published: (2022)

Thymosin beta-4 is elevated in women with heart failure with preserved ejection fraction
by: Drum C.L., et al.
Published: (2020)

2022 HFCT Focused Update of the 2019 HFCT Heart Failure Guidelines: Part 1 - Heart Failure Classification and Pharmacological Treatment for Heart Failure with Reduced Ejection Fraction (HFrEF)
by: Ariyachaipanich A.
Published: (2023)

Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
by: Bai, B., et al.
Published: (2021)

Relationship of anemia and clinical outcome in heart failure patients with preserved versus reduced ejection fraction in a rural area of Thailand
by: Kittayaporn Chairat, et al.
Published: (2020)

Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas
by: Pooja Dewan, et al.
Published: (2020)

Effect of a comprehensive heart failure treatment program on left ventricular ejection fraction and six-minute walk distance in heart failure patients with reduced ejection fraction at Lampang Hospital
by: Boonyapiphat T, et al.
Published: (2020)

Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction
by: Tay, Wan Ting, et al.
Published: (2023)

The Effectiveness of Non-Pharmacological Interventions in Patients with Heart Failure with Preserved Ejection Fraction
by: AMANDA TAN LI YEE
Published: (2021)

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
by: Sweeney, M., et al.
Published: (2021)

Endothelial dysfunction: A pathophysiologic factor in heart failure with preserved ejection fraction
by: Lam, C.S.P., et al.
Published: (2016)

Large animal models of heart failure: Reduced vs. preserved ejection fraction
by: Charles, C.J., et al.
Published: (2021)

Heart Failure Caregiver Burden and Outcomes: A Systematic Review
by: Suksatan W.
Published: (2023)

Heart failure council of Thailand (HFCT) 2019 heart failure guideline: Acute heart failure
by: A. Phrommintikul, et al.
Published: (2019)

Heart failure council of Thailand (HFCT) 2019 heart failure guideline: Advanced heart failure
by: A. Ariyachaipanich, et al.
Published: (2020)

Heart failure council of Thailand (HFCT) 2019 heart failure guideline: Acute heart failure
by: A. Phrommintikul, et al.
Published: (2020)

Heart failure council of Thailand (HFCT) 2019 heart failure guideline: Comorbidity in heart failure
by: S. Chirakarnjanakorn, et al.
Published: (2020)

Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trial
by: Satit Janwanishstaporn, et al.
Published: (2020)

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction. A Community-Based Study
by: Lam, C.S.P., et al.
Published: (2015)

Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction
by: Rungroj Krittayaphong, et al.
Published: (2020)

Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction
by: Rungroj Krittayaphong, et al.
Published: (2020)

Prognostic Value of Global Longitudinal Strain in Patients With Heart Failure With Improved Ejection Fraction
by: Satit Janwanishstaporn, et al.
Published: (2022)

Prognostic Value of Global Longitudinal Strain in Patients With Heart Failure With Improved Ejection Fraction
by: Janwanishstaporn S.
Published: (2023)

Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registry
by: Chanchal Chandramouli, et al.
Published: (2020)

Heart failure council of Thailand (HFCT) 2019 heart failure guideline: Atrial fibrillation in heart failure guidelines
by: T. Chantrarat, et al.
Published: (2019)